Ola Rominiyi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Cancers

British journal of cancer

British journal of neurosurgery

Expert reviews in molecular medicine

University of Sheffield

University of Sheffield (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sheffield Aug 01 2016

United Kingdom

Clinical Research Fellow in Neurosurgery :: Department of Oncology & Metabolism

Sheffield Teaching Hospitals NHS Foundation Trust Aug 01 2014

United Kingdom

Speciality Registrar :: Department of Neurosurgery

Education History

University of Sheffield Oct 01 2016 - Jan 31 2020

United Kingdom

PHD :: Department of Oncology & Metabolism

University of Sheffield Jan 01 2018 - Dec 01 2018

United Kingdom

MSC

The University of Manchester Sep 01 2007 - Jun 01 2008

United Kingdom

BSC

Publications

Callum G Jones, Aurelie Vanderlinden, Ola Rominiyi, Spencer James Collis
Development and Optimisation of Tumour Treating Fields (TTFields) Delivery within 3D Primary Glioma Stem Cell-like Models of Spatial Heterogeneity. Cancers 16 (5) (2024)
Callum G Jones, Aurelie Vanderlinden, Ola Rominiyi, Spencer James Collis
Development and Optimisation of Tumour Treating Fields (TTFields) Delivery within 3D Primary Glioma Stem Cell-like Models of Spatial Heterogeneity. Cancers 16 (5) (2024)
Aurelie Vanderlinden, Callum G Jones, Katie N Myers, Ola Rominiyi, Spencer James Collis
DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells. British journal of cancer (2023)
Sophie T Williams, Greg Wells, Samantha Conroy, Hannah Gagg, Richard Allen, Ola Rominiyi, Thomas Helleday, Katie Hullock, Catherine E W Pennington, Juha K Rantala, Spencer James Collis, Sarah J Danson
Precision oncology using ex vivo technology: a step towards individualised cancer care? Expert reviews in molecular medicine 24 (2022)
George E Richardson, Abdurrahman I Islim, Erminia Albanese, Ahmed Ahmed, Ahmed Aly, Amr Ammar, Michael Amoo, Harsh Bhatt, Peter Bodkin, Ian Coulter, Paula Corr, Ibrahim Elmaadawi, Anne Elserius, Daniel Mark Fountain, K Joshi George, Conor Scott Gillespie, Aimee Goel, Paul L Grundy, Nihal Gurusinghe, Jessica Hartley, Md Tanvir Hasan, Mohsen Javadpour, Neeraj Kalra, Conor Mallucci, Christopher Paul Millward, Belal Mohamed, Saffwan Mohamed, Mohammad A Mustafa, Ravindra Nannapaneni, Deirdre Nolan, Umang J Patel, Rory J Piper, Chittoor Rajaraman, Saba Raza-Knight, Kafeel Rehman, Ola Rominiyi, William Sage, Feras Sharouf, Saurabh Sinha, Murugan Sitaraman, Stuart Smith, Anna Solth, Stuart Stokes, Basel A Taweel, Atul Tyagi, Malik Zaben, Michael D Jenkinson, Manjunath Prasad
Neurosurgery activity levels in the United Kingdom and republic of Ireland during the first wave of the covid-19 pandemic - a retrospective cross-sectional cohort study. British journal of neurosurgery (2021)
Ola Rominiyi, Spencer James Collis
DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies. Molecular oncology (2021)
Natasha Carmell, Ola Rominiyi, Katie N Myers, Connor McGarrity-Cottrell, Aurelie Vanderlinden, Nikita Lad, Eva Perroux-David, Sherif F El-Khamisy, Malee Fernando, Katherine G Finegan, Stephen Brown, Spencer James Collis
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma. Cancers 13 (5) (2021)
Ola Rominiyi, Aurelie Vanderlinden, Susan Jane Clenton, Caroline Bridgewater, Yahia Al-Tamimi, Spencer James Collis
Tumour treating fields therapy for glioblastoma: current advances and future directions. British journal of cancer 124 (4) (2020)
Ola Rominiyi, Yahia Al-Tamimi, Spencer James Collis
The 'Ins and Outs' of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? Cancers 11 (3) (2019)

Ola Rominiyi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ola Rominiyi